The Seventh Affiliated Hospital of Sun Yat Sen University (Shenzhen), Guangdong, Shenzhen, 518000 E-mail:firstname.lastname@example.org, https://orcid.org/0000-0003-1361-1081
Article History Received 5 June 2021 Accepted 25 July 2021 Published 30 September 2021
Cite this Article MO Binyan. Study on the mechanism of Jiawei Linggui Zhugan Decoction in the treatment of myelodysplastic syndrome based on network pharmacological analysis [J].Medical Research, 2021.3(3):50-64, http://dx.doi.org/mrhk/10.6913/MRHK.202109_3(3).0006
Copyright © 2021 Creative Publishing Co., Limited. All rights reserved. Email:email@example.com
Abstract the research method of network pharmacology is used to explore the material basis and mechanism of modified Linggui Zhugan Decoction in the treatment of myelodysplastic syndrome. Methods: the main active components of 8 traditional Chinese medicines of Jiawei Linggui Zhugan Decoction were searched through tcmsp database, and the target was predicted. The relevant targets of myelodysplastic syndrome were searched through geo database, and the common action targets were obtained by intersection of traditional Chinese medicine targets and disease targets. The core targets were selected by topological analysis with Cytoscape software. Finally, go-bp biological function enrichment and KEGG pathway analysis were carried out based on R software. Results: according to the database analysis, there were 248 active compounds and 3695 targets in the modified Linggui Zhugan decoction, of which 34 were common targets with metabolic syndrome; Through the topological analysis of common targets, 9 core targets were selected. Go-bp biological function enrichment and KEGG pathway analysis found that it can play its therapeutic role through p53, AGE-RAGE, cellular sensitivity, NF KB and other signal pathways. Conclusion: modified Linggui Zhugan decoction may play a therapeutic role through p53 signaling pathway, AGE-RAGE signaling pathway, cellular sensitivity, NF kappa B signaling pathway and cell cycle, so as to provide a new scientific basis for its clinical and basic research.
Key Words Jiawei Linggui Zhugan Decoction; myelodysplastic syndrome; network pharmacological analysis